18F-Radiolabeling and Evaluation of an AMD3465 Derivative for PET Imaging of CXCR4 in a Mouse Breast Tumor Model
- 18 April 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (5) , 567-574
Abstract
The exploration of pharmaceutically active agents and positron emission tomography (PET) tracers targeting CXCR4 has been a focal point in cancer research given its pivotal role in the development and progression of various cancers. While significant strides have been made in PET imaging with radiometal-labeled tracers, the landscape of F-18-labeled small molecule tracers remains relatively limited. Herein, we introduce a novel and promising derivative, [F-18]SFB-AMD3465, as a targeted PET tracer for CXCR4. The compound was synthesized by modifying the pyridine ring of AMD3465, which was subsequently labeled with F-18 using [F-18]SFB. The study provides comprehensive insights into the design, synthesis, and biological evaluation of [F-18]SFB-AMD3465. In vitro and in vivo assessments demonstrated the CXCR4-dependent, specific, and sensitive uptake of [F-18]SFB-AMD3465 in the CXCR4-overexpressing 4T1 cell line and the corresponding xenograft-bearing mouse model. These findings contribute to bridging the gap in F-18-labeled PET tracers for CXCR4 and underscore the potential of [F-18]SFB-AMD3465 as a PET radiotracer for in vivo CXCR4 imaging.Keywords
Funding Information
- Henan Provincial Science and Technology Research Project (222102310675)
- Provincial and Ministry jointly built by Henan Medical Science and Technology Research Plan (SBGJ202002007, SBGJ202102015)
This publication has 21 references indexed in Scilit:
- Development and Evaluation of an 18F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 ExpressionMolecular Pharmaceutics, 2019
- [18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4Nuclear Medicine and Biology, 2018
- The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potentialEuropean Journal of Medicinal Chemistry, 2018
- N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic DrugsMolecular Imaging and Biology, 2016
- AMD3100: A Versatile Platform for CXCR4 Targeting 68Ga-Based RadiopharmaceuticalsBioconjugate Chemistry, 2016
- [99mTc]O2-AMD3100 as a SPECT tracer for CXCR4 receptor imagingNuclear Medicine and Biology, 2013
- Fully Automated Preparation and Conjugation of N-Succinimidyl 4-[18F]Fluorobenzoate ([18F]SFB) with RGD Peptide Using a GE FASTlab™ SynthesizerMolecular Imaging and Biology, 2011
- 64Cu-AMD3100—A novel imaging agent for targeting chemokine receptor CXCR4Bioorganic & Medicinal Chemistry, 2009
- Facile synthesis of N‐succinimidyl 4‐[18F]fluorobenzoate ([18F]SFB) for protein labelingJournal of Labelled Compounds and Radiopharmaceuticals, 2008
- Light-Emitting Molecular Machines: pH-Induced Intramolecular Motions in a Fluorescent Nickel(II) Scorpionate ComplexChemistry – A European Journal, 2002